Purchase Order 75N93023P01367
Award Date 9/22/23
Potential Completion Date 12/22/23
Potential Value $708K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Pacific Biosciences of California, Inc. for $384,376 on September 1, 2017 for the Sequel System, with final completion by November 17, 2017. Work is performed in Menlo Park, California. The order is firm fixed-price with no small business set-aside.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,021.25 firm fixed price purchase order to Illumina, Inc. to procure one mid-throughput next generation sequencing instrument or equal. The solicitation sought a sequencing instrument with flowcell options ranging from 100 million to 1.2 billion reads and an onboard bioinformatics server, to be delivered by December 28, 2023 to the Vaccine Research Center...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Pacific Biosciences of California, Inc. to procure specialized reagents for the PacBio Sequel sequencing platform. The $101,845.19 firm fixed-price contract provides the NIAID's Virus Persistence and Dynamics Section with the necessary reagents, such as sequencing kits, binding kits, and consumables, to conduct genomic research on...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Pacific Biosciences of California, Inc. for $480,000 on September 4, 2019, with a firm fixed price for the AMBIS 1967094 Sequel II System. Work is performed in Menlo Park, California. The order is for a next-generation sequencing instrument system and associated consumables. The contract completion date is January 8, 2020.</p>
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $213,150 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 1000 Sequencing System. The award was made under simplified acquisition procedures solicitation number RFQ-NIH-NIAID-2183146, which sought quotes for the sequencing system as well as its delivery to NIH in Bethesda, Maryland, installation, setup, operator training, and maintenance/support services. The...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc. for $104,800.00 to provide a SHORT-READ NEXT GENERATION SEQUENCING PLATFORM (ONSO SYSTEM). The contract does not have a set-aside designation and is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and related services. This award is part of a larger $13.5 million single-award...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Pacific Biosciences of California, Inc. for $15,095.50 on September 9, 2020, with completion by September 30, 2020. The order covers Pacific Bioscience kits and reagents. Performance takes place at the vendor's facility in Menlo Park, California. Pricing is firm fixed price.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...